LONDON--The Medical Research Council (MRC) here has established a venture capital fund of between £30 million and £40 million to provide seed money for biotechnology startups. Companies that derive from MRC-sponsored research will receive 75 percent of the funding. While it has formed alliances with companies in the past, this is the MRC's first foray into backing new companies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.